Dr. Benjamin Philip Levy

Dr. Benjamin Levy is a thoracic medical oncologist uyo anoshandawo semutungamiriri wekiriniki yekurapa oncology yeJohns Hopkins Sidney Kimmel Cancer Center paSibley Memorial Hospital uye semubatsiri purofesa weoncology paJohns Hopkins University School of Medicine. Anoshanda kunze kweSibley Memorial Hospital's Johns Hopkins Sidney Kimmel Cancer Center.

Dr. Levy inyanzvi yesainzi yekiriniki inofarira mune novel immunotherapeutic kurapwa kune varwere vane advanced kenza yemapapu, pamwe chete nemabiomarkers anobatsira kuziva avo varwere vanogona kupindura kumishonga yakadaro. Anonyanya kurwara nechirwere chechipfuva senge isiri-diki kenza yemapapu, kenza diki yemapapu, thymic malignancies, uye. kenza yemusoro neyemutsipa.

Dr. Levy vakapedza kudzidza kubva kuMedical College yeGeorgia. Akapedza kugara kwemishonga yemukati kuGeorgetown University Hospital, achiteverwa nehematology / oncology kuyanana kuNew York Presbyterian/Weill Cornell Medical Center, kwaakagamuchira Dhipatimendi reMedicine Research Fellow of the Year Award uye 2009 American Society of Clinical Oncology Young. Muongorori Mubairo wake Kenza yeprotate tsvakurudzo yekiriniki. Dr. Levy akamboshanda semubatsiri purofesa paIcahn School of Medicine, semutungamiri wezvokurapa we thoracic oncology yeMount Sinai Health Systems, uye semubatsiri mukuru weMount Sinai Hospital's Cancer. Clinical Trials Office.

Dr. Levy vakashanda mumakomiti akawanda eAmerican Society of Clinical Oncology (ASCO) uye parizvino mupepeti weASCO University Committee. Akashanda pabhodhi rekunyora reJournal of Clinical Oncology kwemakore maviri uye parizvino ari muongorori wezve ad hoc kune mamwe mabhuku akadai seClinical Lung Cancer, The Oncologist, uye Onco chinangwa. Dr. Levy achangobva kusarudzwa semumwe wevane 15 oncologists munyika kuti vatore chikamu chepamusoro cheASCO Leadership Development chirongwa, icho chine chinangwa chekutsvaga nekudzidzisa vatungamiri veASCO mune ramangwana. Dr. Levy vanoshandawo paAlliance Respiratory Committee, IASLC Staging Committee, uye IASLC Career Development & Fellowship Committee mukuwedzera kumabasa ake eASCO.

• Kanza yemaperembudzi
• immunotherapy

Becker DJ, Wisnivesky JP, Grossbard ML, Chachoua A, Camidge DR, Levy BP. "Kupona kweVakadzi vekuAsia Nekenza Yepamberi Yemapapu munguva yeTyrosine Kinase Inhibitor Therapy." Clin Lung Cancer. 2017 Jan;18(1):e35-e40. doi: 10.1016/j.cllc.2016.08.008.

Levy BP, Rao P, Becker DJ, Becker K. "Kurwisa Chinangwa Chinofamba: Kunzwisisa Kuramba uye Kugadzirisa Kufambira Mberi muEGFR-Positive Lung Cancer Varwere Vanobatwa neTyrosine Kinase Inhibitors." Oncology (Williston Park). 2016 Jul;30(7):601-12. Ongorora.

Levy BP, Chioda MD, Herndon D, Longshore JW, Mohamed M, Ou SH, Reynolds C, Singh J, Wistuba II, Bunn PA Jr, Hirsch FR. "Kuyedzwa kwemaMolecular Kurapa kweMetastatic Isiri Idiki Cell Lung Cancer: Maitiro Ekushandisa Uchapupu-hwakavakirwa Mazano." Oncologist. 2015 Oct;20(10):1175-81. doi: 10.1634/theoncologist.2015-0114.

Rizvi NA, Mazières J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E, Mennecier B, Otterson GA, Campos LT, Gandara DR, Levy BP, Nair SG, Zalcman G, Wolf J, Souquet PJ, Baldini E, Cappuzzo F, Chouaid C, Dowlati A, Sanborn R, Lopez-Chavez A, Grohe C, Huber RM, Harbison CT, Baudelet C, Lestini BJ, Ramalingam SS . "Basa uye kuchengetedzeka kwenivolumab, anti-PD-1 immune checkpoint inhibitor, kune varwere vane advanced, refractory squamous isiri-diki-cell cancer yemapapu (CheckMate 063): chikamu 2, imwe-ruoko ruyedzo." Lancet Oncol. 2015 Mar;16(3):257-65. doi: 10.1016/S1470-2045(15)70054-9.

Levy BP, Becker DJ. "Nguva yekudzikira-dose computed tomography yekuongorora ikozvino: maonero ekurapa oncologist." Oncology (Williston Park). 2014 Nov;28(11):964-6. Hapana abstract iripo.